Clinical Trials in Phoenix

Showing 6341-6360 of 16,646 trials

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

NCT05131646

This is an open-label, non-interventional extension study of up to 12 weeks in duration in subjects completing Cohorts 2, 3, and 4 of the Parent study, CLS1002-101.

Neovascular Age-related Macular Degeneration

Clearside Biomedical, Inc.15 participantsStarted Oct 2021

Phoenix, Arizona, United States • Mountain View, California, United States • Sacramento, California, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

NCT04859660

The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.

Urinary Retention Postoperative

University of Arizona161 participantsStarted Apr 2021

Phoenix, Arizona, United States • Tucson, Arizona, United States

COMPLETED< 1 mile

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

NCT01474811

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

Hepatitis C

University of North Carolina, Chapel Hill13,559 participantsStarted Nov 2011

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +57 more locations

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Find Trials by Condition in Phoenix

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

OCS Lung System EXPAND II Trial

NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2

Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

ACS Community Access to Resources Education and Support

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19

Pilot Prospective Study: Long-term Health of Living Kidney Donors

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

A Clinical Trial of PRAX-944 in Participants With Essential Tremor

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)